GIP/GLP1 CO-AGONIST COMPOUNDS

The present invention relates to compounds having activity at both the human glucose-dependent insulinotropic polypeptide (GIF) and glucagon-like peptide-1 (GLP-1) receptors. The present invention also relates to compounds having an extended duration of action at each of these receptors. Furthermore...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	CABRERA Over, ELSAYED Mohamed Elsayed Hamed, ABRAHAM Milata Mary, BROWN Robert Andrew, COSKUN Tamer, WILLARD Francis Stafford, DATTA-MANNAN Amita, TRAN Thi Thanh Huyen, PATEL Phenil Jayantilal, WALLIS James Lincoln, ALSINA-FERNANDEZ Jorge, LAI Xianyin, SLOOP Kyle Wynn, QU Hongchang, ABURUB Aktham, CUMMINS Robert Chadwick
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!